[
  {
    "ts": "2026-01-30T07:07:14+00:00",
    "headline": "Goldman Sachs Highlights BioNTech’s (BNTX) Immuno-Oncology and ADC Pipeline",
    "summary": "BioNTech SE (NASDAQ:BNTX) ranks among the best high growth European stocks to buy. On January 16, Goldman Sachs upgraded BioNTech SE (NASDAQ:BNTX) from Neutral to Buy and boosted its price target from $115 to $142, highlighting the company’s key position in oncology. According to the firm, BioNTech SE (NASDAQ:BNTX) stands “at the nexus of significant […]",
    "url": "https://finance.yahoo.com/news/goldman-sachs-highlights-biontech-bntx-070714973.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "06d9eb93-ed05-30e6-bb5a-050941caaab9",
      "content": {
        "id": "06d9eb93-ed05-30e6-bb5a-050941caaab9",
        "contentType": "STORY",
        "title": "Goldman Sachs Highlights BioNTech’s (BNTX) Immuno-Oncology and ADC Pipeline",
        "description": "",
        "summary": "BioNTech SE (NASDAQ:BNTX) ranks among the best high growth European stocks to buy. On January 16, Goldman Sachs upgraded BioNTech SE (NASDAQ:BNTX) from Neutral to Buy and boosted its price target from $115 to $142, highlighting the company’s key position in oncology. According to the firm, BioNTech SE (NASDAQ:BNTX) stands “at the nexus of significant […]",
        "pubDate": "2026-01-30T07:07:14Z",
        "displayTime": "2026-01-30T07:07:14Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/382f812a97a6f4b17398b231c6857399",
          "originalWidth": 1000,
          "originalHeight": 668,
          "caption": "Zoetis (ZTS) Hits New 52-Week Low on Dismal Outlook",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ePZnwRNsj5HbV2hcoJO.cA--~B/aD02Njg7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/382f812a97a6f4b17398b231c6857399.cf.webp",
              "width": 1000,
              "height": 668,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/L1g81T6.O1vVFeurSCF6UA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/382f812a97a6f4b17398b231c6857399.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/goldman-sachs-highlights-biontech-bntx-070714973.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/goldman-sachs-highlights-biontech-bntx-070714973.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BNTX"
            },
            {
              "symbol": "GS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]